We are a leading company specializing in the business of offering our clients Ticlopidine. This drug is an effective inhibitor of platelet aggregation. The drug blocks the ADP receptor that is involved in GPIIb/IIIa receptor activation leading to platelet aggregation. It is indicated for patients who cannot take aspirin or in whom aspirin has not worked to prevent a thrombotic stroke. Ticlopidine is used to decrease the risk of stroke in patients known to have atherosclerosis. It is a white crystalline solid, freely soluble in water and dissolves freely in methanol.